Table 5 Patient characteristics and a single-predictor analysis of overall survival
From: A single-center experience: management of patients with thymic epithelial tumors
Characteristics | No. | % | Mean survival (95 % CI) | P (log-rank test) |
|---|---|---|---|---|
Gender | 0.870 | |||
Female | 26 | 65 | 119 (95–144) | |
Male | 14 | 35 | 118 (76–161) | |
Age, years | 0.755 | |||
≤ 60 | 26 | 65 | 121 (93–151) | |
> 60 | 14 | 35 | 105 (70–141) | |
Masaoka-Koga stage | < 0.001 | |||
I | 10 | 27 | 142 (117–168) | |
II | 15 | 41 | 111 (83–138) | |
III | 4 | 11 | 72 (44–100) | |
IV | 8 | 22 | 21 (10–32) | |
Surgical technique | 0.001 | |||
Minimally invasive | 20 | 50 | 162 (139–185) | |
Open | 20 | 50 | 79 (48–111) | |
Resection status | 0.012 | |||
R0 | 27 | 68 | 142 (115–168) | |
R1 | 11 | 28 | 71 (40–102) | |
R2 | 2 | 5 | 23 (16–29)) | |
Adjuvant radiotherapy | 0.578 | |||
Yes | 15 | 37 | 84 (60–109) | |
No | 25 | 62 | 126 (96–156) | |
Adjuvant chemotherapy | 0.001 | |||
Yes | 8 | 20 | 38 (14–62) | |
No | 32 | 80 | 138 (113–162) | |
Clavien-Dindo classification | 0.012 | |||
I–IIIa | 32 | 80 | 135 (109–161) | |
IIIb–IV | 8 | 20 | 55 (20–90) | |